Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Belgium
/
Healthcare
Create a narrative
Fagron Community
ENXTBR:FAGR Community
1
Narratives
written by author
0
Comments
on narratives written by author
9
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
Fagron
Popular
Undervalued
Overvalued
Fagron
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
APAC Expansion And Compounding Services Will Unlock Future Value
Key Takeaways Expansion into new regions and focus on personalized pharmaceuticals positions Fagron for future global growth as demand rises from aging populations and chronic conditions. Investment in automation, facility expansion, and quality strengthens operational efficiency and market leadership, paving the way for margin and earnings growth.
View narrative
€24.84
FV
17.1% undervalued
intrinsic discount
7.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
FAGR
FAGR
Fagron
Your Fair Value
€
Current Price
€20.60
5.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-31m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue €1.3b
Earnings €122.6m
Advanced
Set Fair Value